Skip to main content

Building biotech and raising venture capital financing: Pureos Bioventures, Alentis and Engimmune (EN)

Date

27.09.22

Time

18:00 - 19:30

Location

Halle 7
Gundeldingerfeld, Dornacherstrasse 192, 4053 Basel

Language

English
Stephan Emmerth

Organizer

Stephan Emmerth
Email
stephan.emmerth@baselarea.swiss

Other Organizers

BaseLaunch invites you to this biotech networking event empowered by Innosuisse featuring Pureos Biovetures, Alentis Therapeutics and Engimmune Therpaueutics.

Launching and financing a biotech company is a challenging endeavor with many things to get right from the beginning. Besides the science side requiring heavy de-risking, the business aspects like building a team, licensing the IP, strategic decisions concerning the pipeline and lead indications as well as the business plans require attention too.

All of this requires the scientific founders to leave their comfort zone but is crucial to build the foundation for the initial financing and future growth of the company.

This event will feature two successful scientific founders, who will share their stories: Prof. Thomas Baumert from Alentis Therapeutics which raised over CHF $80M in venture capital and Dr. Rodrigo Vazquez-Lombardi from Engimmune Therapeutics who closed a seed financing of $16.7M this year. In addition, we are very proud that Dominik Escher from Pureos Bioventures – one of our BaseLaunch partners and early investor in both companies – is joining us to share his perspective on partnering with early-stage founders.

Program

17:30

Door opening

18:00

Welcome
Stephan Emmerth, BaseLaunch

18:10

Pureos Bioventures
Dominik Escher

18:20

Alentis Therapeutics
Thomas Baumert

18:50

Engimmune Therapeutics
Rodrigo Vazquez-Lombardi

19:20

Q & A
with all speakers

19:30

Networking Apéro

Participation is free, however registration is required before August 17th, 2022.

Our partners